Researchers and policy makers in the US are exploring the implementation of health technology assessment and value-based pricing to negotiate drug prices …
Posted inTechnology News
Controversy Over Using Quality-Adjusted Life-Years In Cost-Effectiveness Analyses – Health Affairs
